Application 220367
- Type
- ANDA
- Sponsor
- STERANCO HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | SUSPENSION;ORAL | 100,000 UNITS/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220367-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | 2026-02-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | 2026-02-05 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | 2026-02-05 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2026-02-05 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2026-02-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A220367-001 | AA | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220367-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NYSTATIN | NYSTATIN | Aurobindo Pharma Limited | 7d8a30ab-465e-4804-a06b-afd689e16683 | 2025-06-18 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | a1b5ccb2-d0d6-46cc-b792-6920b50d0a03 | 2025-05-15 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 72dc2b60-29a4-48a8-848a-1a5086cfdd58 | 2025-04-03 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | cc8f9a06-cd1b-40e9-bc22-7e19f6d89b83 | 2025-04-02 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | cf6b7c68-7769-1808-e053-2995a90aa426 | 2025-02-10 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Padagis Israel Pharmaceuticals Ltd | 6c091c66-2e4d-4412-b7bf-35315dc8152f | 2025-01-23 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | DIRECT RX | cd387929-5b72-e3c0-e053-2a95a90adb22 | 2025-01-20 | Adverse reactions | NYSTATIN NYSTATIN |
| NYSTATIN | NYSTATIN | NuCare Pharmaceuticals,Inc. | 0b4dfd5e-641e-40e9-e063-6294a90a3fda | 2025-01-03 | Adverse reactions | NYSTATIN NYSTATIN |
| NYSTATIN | NYSTATIN | Zydus Lifesciences Limited | 5d593aa9-f2e4-4adf-9f02-37832ffcb5b4 | 2024-12-03 | NYSTATIN NYSTATIN | |
| NYSTATIN | NYSTATIN | Leading Pharma, LLC | 954205d8-47ba-4c89-95cd-f0066a514cf9 | 2024-11-28 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | 6599b544-60bd-ab30-e053-2a91aa0a67b6 | 2024-11-20 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | f410ba07-9183-40a8-a2a6-46d3e9761470 | 2024-11-06 | Adverse reactions | Nystatin NYSTATIN |
| Nystop | NYSTATIN | Padagis US LLC | e1b4622c-0f9f-4c00-b42c-2aa85a5e3d4f | 2024-10-31 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | A-S Medication Solutions | 65167baa-29f8-44d3-b2d2-935c862d463e | 2024-10-16 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | b69d9035-bdf5-4c5a-94d8-f8438f6f0567 | 2024-08-27 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Zydus Lifesciences Limited | 6aa2f67e-9636-45e5-be1b-83e7ab86e436 | 2024-08-16 | Nystatin NYSTATIN | |
| Nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | 57825c04-dcb5-b76d-e053-2991aa0a4c1d | 2024-08-14 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | 86cfb84c-dcd3-b229-e053-2a91aa0aed5c | 2024-08-14 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Leading Pharma, LLC | 089e6444-2bd1-443e-acf0-dfeaa69faef9 | 2024-04-18 | NYSTATIN NYSTATIN | |
| Nystatin | NYSTATIN | Dr. Reddy's Labratories Inc. | 6bde84a1-341d-09ce-58b6-f9a653dc98c5 | 2024-04-12 | Adverse reactions | Nystatin NYSTATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.